OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
Yurong Peng, Zhuo Li, Yucheng Fu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Yurong Peng, Zhuo Li, Yucheng Fu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Showing 13 citing articles:
Navigating the landscape of neoadjuvant immunotherapy for NSCLC: progress and controversies
Yuzhu Chen, Fei Qi, Chao Sun, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Yuzhu Chen, Fei Qi, Chao Sun, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Comparison of programmed death ligand-1 expression in preoperative transbronchial lung biopsy and resected specimens in non-small cell lung cancer
Naoko Shigeta, Shuji Murakami, Kouji Yamamoto, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 4
Open Access
Naoko Shigeta, Shuji Murakami, Kouji Yamamoto, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 4
Open Access
A narrative review on perioperative systemic therapy in non-small cell lung cancer
Robert Hsu, Zhaohui Arter, Darin Poei, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 931-954
Open Access | Times Cited: 3
Robert Hsu, Zhaohui Arter, Darin Poei, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 931-954
Open Access | Times Cited: 3
Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC
Evangelia Bogatsa, George Lazaridis, Chrysoula Stivanaki, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1619-1619
Open Access | Times Cited: 2
Evangelia Bogatsa, George Lazaridis, Chrysoula Stivanaki, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1619-1619
Open Access | Times Cited: 2
Perioperative immunotherapy in nonsmall cell lung cancer
Renzhi Zhang, Chun Zou, Liang Zeng, et al.
Current Opinion in Oncology (2024)
Closed Access | Times Cited: 2
Renzhi Zhang, Chun Zou, Liang Zeng, et al.
Current Opinion in Oncology (2024)
Closed Access | Times Cited: 2
A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review
Safa Can Efil, Burak Bi̇lgi̇n, Furkan Ceylan, et al.
Journal of Oncology Pharmacy Practice (2024) Vol. 30, Iss. 7, pp. 1214-1239
Closed Access | Times Cited: 1
Safa Can Efil, Burak Bi̇lgi̇n, Furkan Ceylan, et al.
Journal of Oncology Pharmacy Practice (2024) Vol. 30, Iss. 7, pp. 1214-1239
Closed Access | Times Cited: 1
Perioperative Immuntherapie beim operablen Lungenkarzinom: aktuelle Studienlage und neue Therapiestandards
Uyen‐Thao Le, Birte Ohm, Severin Schmid
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie (2024) Vol. 149, Iss. S 01, pp. S35-S44
Closed Access | Times Cited: 1
Uyen‐Thao Le, Birte Ohm, Severin Schmid
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie (2024) Vol. 149, Iss. S 01, pp. S35-S44
Closed Access | Times Cited: 1
Shenqifuzheng injection inhibits lactic acid-induced cisplatin resistance in NSCLC by affecting FBXO22/p53 axis through FOXO3
Bo Wei, Xiaokai Wang, Ning Yu, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Bo Wei, Xiaokai Wang, Ning Yu, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
PD-1 and PD-L1 expression in rare lung tumors
Márton Gyulai, Zsolt Megyesfalvi, Lilla Reiniger, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 3
Márton Gyulai, Zsolt Megyesfalvi, Lilla Reiniger, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 3
Efficacy and Safety of Perioperative Immunotherapy for Non-Small Cell Lung Cancer: A Network Meta-Analysis
Shuxing Wang, Xinyu Tian, Zhuqing Liu, et al.
(2024)
Closed Access
Shuxing Wang, Xinyu Tian, Zhuqing Liu, et al.
(2024)
Closed Access
Perioperative Immuntherapie beim operablen Lungenkarzinom: aktuelle Studienlage und neue Therapiestandards
Uyen‐Thao Le, Birte Ohm, Severin Schmid
TumorDiagnostik & Therapie (2024) Vol. 45, Iss. 09, pp. 604-613
Closed Access
Uyen‐Thao Le, Birte Ohm, Severin Schmid
TumorDiagnostik & Therapie (2024) Vol. 45, Iss. 09, pp. 604-613
Closed Access
Global trends and research hotspots in perioperative management of lung cancer: a bibliometric analysis from 2004 to 2024
Qinling Jiang, Zhiqiang Wei, Pingping Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Qinling Jiang, Zhiqiang Wei, Pingping Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Induction chemoimmunotherapy may improve outcomes to chemoradiotherapy for unresectable stage III NSCLC patients
Song Guan, Shufeng Zhang, Kai Ren, et al.
Research Square (Research Square) (2023)
Open Access
Song Guan, Shufeng Zhang, Kai Ren, et al.
Research Square (Research Square) (2023)
Open Access
